BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4800565)

  • 1. [Pulmonary surfactant system in respiratory physiology and clinical practice].
    Motles E
    Rev Med Chil; 1973 Jan; 101(1):74-83. PubMed ID: 4800565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surface-active factor of the lungs (surfactant) in certain diseases of the respiratory organs].
    Puchkov GF; Iazvinskiĭ II
    Sov Med; 1975 Aug; (8):62. PubMed ID: 1105810
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pulmonary surfactant].
    Murakami K; Ono K; Fujiwara T; Sawada H; Mori I
    Nihon Ishikai Zasshi; 1971 Jul; 66(1):100-16. PubMed ID: 4254974
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pulmonary surfactant: anti-atelectasis factor].
    Ouellet Y
    Laval Med; 1970 May; 41(5):627-30. PubMed ID: 4928481
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulmonary surfactants].
    Pariente R; André-Bougaran J; Legrand M; Cayrol E; Leturcq E
    Pathol Biol (Paris); 1973 Feb; 21(2):197-208. PubMed ID: 4266994
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relation between citicoline and pulmonary surfactant. Recent acquisitions in the treatment of respiratory syndromes of the newborn].
    Colombo ML; Dogliani P; Raggi M
    Minerva Pediatr; 1976 Nov; 28(37):2303-10. PubMed ID: 1036757
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of shock on atelectatic pulmonary shunting.
    Wahrenbrock EA; Carrico CJ; Amundsen DA; Trummer MJ
    Surg Forum; 1969; 20():223-5. PubMed ID: 5383058
    [No Abstract]   [Full Text] [Related]  

  • 8. [The surfactant system of the lungs in the postoperative period].
    Mustafin AKh; Sinel'nikov AL; Petrova LD
    Anesteziol Reanimatol; 1991; (1):60-3. PubMed ID: 1862971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant of the lung.
    Heinemann HO
    Adv Intern Med; 1968; 14():83-105. PubMed ID: 4883747
    [No Abstract]   [Full Text] [Related]  

  • 10. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological effects of reduction in lung surfactant.
    Reynolds EO
    Proc R Soc Med; 1973 Apr; 66(4):388-9. PubMed ID: 4740402
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O; Kale G
    Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The presence of the "surfactant-system" in the lung as a condition for the repression of upper respiratory tract diseases. 3. Clinical material].
    Wildeboer-Venema FN
    Ned Tijdschr Geneeskd; 1971 Sep; 115(37):1533-8. PubMed ID: 5109628
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pulmonary hyaline membranes in newborns and adults - morphology and pathogenesis (literature review). Part 2. Pathogenesis].
    Kretschmar K; Heber J
    Z Arztl Fortbild (Jena); 1978 Nov; 72(21):1009-13. PubMed ID: 369156
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of exogenous cholinesterase on the pulmonary surfactant system after massive blood loss].
    Zeliak VI; Bazarevich GIa; Norman TN; Leksina AK
    Patol Fiziol Eksp Ter; 1984; (5):8-11. PubMed ID: 6549059
    [No Abstract]   [Full Text] [Related]  

  • 16. The pulmonary surfactant.
    Sekabunga JG
    East Afr Med J; 1973 Jan; 50(1):27-32. PubMed ID: 4578486
    [No Abstract]   [Full Text] [Related]  

  • 17. RESPIRATORY PHYSIOLOGY AND RESPIRATORY DISTRESS IN THE NEWBORN INFANT.
    SMITH CA
    Int Anesthesiol Clin; 1965 Feb; 3():209-24. PubMed ID: 14299001
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications and methods of oxygenation and artificial respiration in hyaline membrane disease].
    Huault G; Gajer M; Kachaner J; Saint-Martin J; Joly JB
    Ann Med Interne (Paris); 1972 Feb; 123(2):125-8. PubMed ID: 5068608
    [No Abstract]   [Full Text] [Related]  

  • 19. A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease.
    Cotton RB
    Semin Perinatol; 1994 Feb; 18(1):19-22. PubMed ID: 8209282
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lung and lipids (author's transl)].
    Loute G
    Acta Tuberc Pneumol Belg; 1974; 65(2):177-99. PubMed ID: 4608155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.